Isomorphic Labs Raises $5 Billion for AI Drug Design
Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.
By: The Defiant •
AI
Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.
Loading this article…